Lista de obras -

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

artículo científico publicado en 2017

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

artículo científico publicado en 2010

Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design

artículo científico publicado en 2007

Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error ⬇️

artículo científico publicado el 5 de julio de 2012

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

scientific article published on 15 October 2019

Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines

artículo científico publicado en 2004

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

artículo científico publicado en 2016

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop

artículo científico publicado en 2007

Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection.

artículo científico publicado en 2009

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

artículo científico publicado en 2008

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial ⬇️

artículo científico publicado el 27 de febrero de 2011

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

artículo científico publicado en 2013

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond ⬇️

artículo científico publicado el 1 de marzo de 2012

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

artículo científico publicado en 2015

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

artículo científico publicado en 2015

High-throughput flow cytometry data normalization for clinical trials.

artículo científico publicado en 2013

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

artículo científico publicado en 2012

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

artículo científico publicado en 2007

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial

artículo científico publicado en 2013

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection

artículo científico publicado en 2011

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

article

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

artículo científico publicado en 2017

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

artículo científico publicado en 2016

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

artículo científico publicado en 2009

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape

artículo científico publicado en 2012

nCal: an R package for non-linear calibration ⬇️

artículo científico publicado el 6 de agosto de 2013

Lista de obras de

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes

Capturing viral diversity for in-vitro test reagents and HIV vaccine immunogen design

Comparing and combining data across multiple sources via integration of paired‐sample data to correct for measurement error ⬇️

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines

Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop

Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection.

Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection

Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial ⬇️

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond ⬇️

HIV-1 infections with multiple founders are associated with higher viral loads than infections with single founders

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

High-throughput flow cytometry data normalization for clinical trials.

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

Vertical T cell immunodominance and epitope entropy determine HIV-1 escape

nCal: an R package for non-linear calibration ⬇️